Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study
Clinical Infectious Diseases·
- DOI
- 10.1093/cid/ciaf524
- PMID
- 41504567
- PMCID
- PMC12781193
- OpenAlex
- W7119506964
- Study type
- Mathematical modelling
- Publisher
- Oxford University Press (OUP)
- Article type
- journal-article
- Integrity
- current
Why this research matters now
These projections inform strategic planning for managing resistance risks associated with upcoming therapeutic approvals for sexually transmitted infections.
Structured evidence summary
Research question
The investigation evaluates whether simultaneous or phased distribution of novel antimicrobials more effectively curbs resistance development during gonorrhea management.
Study design
Researchers applied a stochastic compartmental mathematical framework to project resistance trajectories under alternative pharmaceutical distribution protocols.
Population and setting
The computational environment simulated transmission dynamics among men who have sex with men located within the United States.
Main findings
Model outputs indicated that uniform drug distribution consistently postponed or avoided crossing the five percent resistance benchmark relative to phased deployment. The phased approach achieved the resistance milestone more frequently across virtually all evaluated parameter scenarios.
Public-health relevance
These projections inform strategic planning for managing resistance risks associated with upcoming therapeutic approvals for sexually transmitted infections.
Important limitations
The analysis is constrained by its dependence on the provided abstract and metadata alone. Decision-grade interpretation requires examination of the original manuscript to verify model specifications and parameter ranges.
GIDS interpretation
This record establishes a theoretical baseline for contextualizing resistance trends linked to emerging gonorrhea interventions within the defined demographic region. It functions as a reference for modeled scenario outcomes rather than an indicator of current monitoring activities.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 7 auditable classifier relationships to diseases, places, topics, and study design.